Zilovertamab vedotin (MK-2140) plus R-CHP in people with the GCB DLBCL

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  1011281

• Contact name

  - -

• Contact email

  -

• Sponsor organisation

  Publication of this data is currently deferred.

• Clinicaltrials.gov Identifier

  NCT06890884

• Research summary

  Publication of this data is currently deferred.

• REC name

  London - London Bridge Research Ethics Committee

• REC reference

  25/LO/0111

• Date of REC Opinion

  2 May 2025

• REC opinion

  Further Information Favourable Opinion